A substrain of the senescence-accelerated mouse (SAM), the SAMP1 mouse, is an animal model for accelerated senescence including the age-related acceleration of both immunological dysfunction and hearing loss caused by the impairment of spiral ganglion cells. In the present study, we examine whether the accelerated presbycusis can be prevented by allogeneic BMT. Young SAMP1 (H-2 k ) mice were irradiated with 9 Gy and then reconstituted with bone marrow cells from normal BALB/c (H-2 d ) mice. Allogeneic BMT was found to prevent the development of immunological dysfunction, hearing loss, and apoptosis of spinal ganglion cells in SAMP1 mice. These findings indicate that some types of accelerated presbycusis do not result from defects in the cochlea, but do from defects in the hematopoietic stem cells (HSC) and immunocompetent cells derived from the HSC. If this is the case, either allogeneic BMT, which replaces abnormal HSC with normal HSC and reconstructs a normal immune system in the recipients, or autologous BMT using genetically modified bone marrow cells, could become a new strategy for the treatment of presbycusis. Bone Marrow Transplantation (2001) 28, 323-328. Keywords: presbycusis; spiral ganglion cell; bone marrow transplantation; T lymphocyte; apoptosis There has been no strategy for the prevention and treatment of presbycusis. There is a widespread presumption based on clinical observations that presbycusis is an inherited disorder, and that genetic factors may influence both the rate and severity of the hearing loss.
loss with an onset at an early age, as well as accelerated senescence in an inherited pattern. 4, 5 Molecular studies, such as transfer experiments of the Akv-1 gene 4 and apoA-II gene, 6 are in progress. Age-accelerated somatic mutations were also found in the hypoxanthine phosphoribosyl transferase (Hprt) locus of splenic lymphocytes. 7 This mouse strain shows an early occurrence of accelerated dysfunctions of immunocompetent cells, particularly T cells, 4, 8 followed by accelerated hearing impairment, 5 the loss of physical activity, alopecia, periophthalmic lesions, and increased lordokyphosis of the spine, as well as spontaneous age-associated amyloidosis and shortened lifespan. 9, 10 Early production of autoantibodies against DNA, thymocytes and collagen type II and the early deposition of immune complexes in the glomeruli of the kidney have been demonstrated in these mice. 11 Since age-related changes in the immune system appear relatively early in life, it is suggested that immune impairment may be a cause of age-related disease. 4 We have previously shown that the dysfunctions of immunocompetent cells, but not abnormalities in the cochlea, cause the development of autoimmune sensori-neural hearing loss resulting from the deposits of autoantibodies to cochlea in autoimmune-prone MRL/lpr mice. 12 We have also demonstrated that the hearing loss and cochlear pathology are derived from defects in the bone marrow cells; BMT can be used to prevent the development of the sensori-neural hearing loss. 13 If senescence is accelerated by the dysfunctions of immunocompetent cells, the normalization of the immune system by allogeneic BMT should prevent accelerated senescence. Therefore, we examine whether allogeneic BMT can prevent the accelerated impairment of both immune functions and hearing. 
Materials and methods

Animals
Bone Marrow Transplantation
These mice were maintained under specific pathogen-free conditions in our animal facilities. BMT SAMP1 mice (2 months old) were lethally irradiated with 9 Gy from a 137 Cs source (Gammacell 40 Exactor; Nordion International Inc., Ontario, Canada). One day later, these mice were injected intravenously with 4 × 10 7 bone marrow cells from 2-month-old BALB/c mice; the bone marrow cells had been incubated with anti-Thy1.2 antibody (antimouse panT cell antibody, clone F7D5; Serotec Ltd, Bicester, UK) for 30 min at 4°C, washed, and resuspended with rabbit complement for 30 min at 37°C to delete T cells, which cause graft-versus-host (GVH) reaction. SAMP1 and BALB/c mice without BMT were also used as controls.
Flow cytometry
Spleen cells (1 × 10 6 ) were suspended in phosphate-buffered saline (PBS) containing 2% fetal calf serum (FCS) plus 0.05% sodium azide, then incubated on ice with FITCcoupled anti-H-2 k or anti-H-2 d antibody (Ab) (Meiji Institute of Health Science, Odawara, Kanagawa, Japan). The stained cells were analyzed on a FACStar (Becton Dickinson, San Jose, CA, USA).
Mitogen response
The proliferative responses of spleen cells were evaluated by counting the incorporation of [ ) were cultured for 72 h in 96-well flat-bottomed microculture plates (Corning Glass Works 25860, Corning, NY, USA) with concanavalin A (Con A; 2.5 g/ml, Calchem-Behring, San Diego, CA, USA), or phytohemagglutinin (PHA; 25 g/ml, Difco, Detroit, MI, USA) in RPMI-1640 medium containing 10% FCS, 5 × 10 −5 m 2-mercaptoethanol (2-ME; Wako, Osaka, Japan) and 2 mm glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. [ 3 H]-thymidine (0.5 mCi; 1 Ci = 3.7 × 10 10 Bq, New England Nuclear, Boston, MA, USA) was introduced to each culture 16 h prior to termination. The cells were then aspirated from the wells with a semiautomatic sample collector and dried on filters, and their radioactivity was then determined using a liquid scintillation counter.
Mixed lymphocyte reaction (MLR)
Spleen cells were used for one-way MLR, as previously described.
14 Triplicate cultures were set up in 96-well round-bottomed microculture plates (Corning, 25850) after stimulator cells were irradiated with 25 Gy. Each well contained 5 × 10 5 responder cells and 2.5 × 10 5 stimulator cells in a total volume of 0.2 ml RPMI-1640 medium supplemented with 10% FCS, 5 × 10 −5 m 2-ME, 2 mm glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. The cultures were incubated for 96 h, and the radioactivity was counted, as described under Mitogen response.
Auditory brainstem response (ABR)
The auditory function of the mice was evaluated by their ABR 3 months after BMT. ABR is an evoked potential measurement of auditory activity of the cochlea, auditory nerve, and central auditory pathway in the brainstem. It is often used as a technique in auditory aging research in humans and laboratory animals. 15, 16 Prior to testing, the mice were anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and atropine sulfate (0.5 mg/kg, i.p.). Otoscopic and histopathological examinations revealed that the tympanic membranes or tympanic cavities were normal in all mice. Needle electrodes were inserted into the occiput, vertex and hindpaw (ground). The click stimuli (0.1 ms) were produced using a sound stimulator (Neuropack ⌺ MEB-5504, Nihon Kohden, Tokyo, Japan). The stimulus was set at the rate of 20 clicks per s, and averaged 1000 clicks. The peak frequency of the stimulus was set to 4000 Hz since SAMP1 mice have been reported to show age-related hearing impairment above 2000 Hz. 5 The speaker was located 100 cm from the tragus of the stimulated ear. The frequency and intensity (dBpeSPL) of the stimuli at the ear drum of each mouse were confirmed using an oscilloscope and a calibration microphone in a preliminary study. ABRs were obtained by decreasing the stimuli in 2-or 4-dB steps from a maximum intensity of 106 dBpeSPL. The threshold was visually defined as the lowest intensity producing a clearly visible first wave corresponding with activity recorded directly from the cochlea and auditory nerve.
Histopathological examination and in situ detection of nuclear DNA fragmentation in spiral ganglion cells
After ABR and splenectomy, five mice from each group were subjected to intracardiac perfusion with saline, followed by periodate-lysin-paraform aldehyde (PLP) fixation and decalcification at 4°C in 5% buffered ethylene diaminetetra-acetate (EDTA) for 7 days at room temperature. The temporal bones were dehydrated in a graded series of ethanol, passed through xylene, then embedded in paraffin. Serial 6-m thick modiolar sections were cut and stained with cresyl violet for histopathological examination. Four sections from each animal were processed for in situ detection of DNA fragmentation using the terminal dinucleotidyltransferase-mediated uridine triphosphate end labeling (TUNEL) method as described by Gavrieli et al 17 to observe the spiral ganglion cells that show age-related acceleration of degeneration in untreated SAMP1 mice according to the manufacturer's instructions (Apop Tag kit; Oncor, Inc., Gaithersburg, MD, USA). Briefly, the sections were incubated with proteinase K (20 g/ml) for 15 min at room temperature. This was followed by two consecutive washes in water and by quenching endogenous peroxidase in PBS containing 3.0% hydrogen peroxidase in PBS. After treatments with terminal dioxynucleotidyl transferase in a humidified chamber at 37°C for 1 h and with antidigoxigenin peroxidase in a humidified chamber at room temperature for 30 min, they were washed in four changes of PBS and exposed to 0.05% diaminobenzidine and 0.002% hydrogen peroxide. The sections were then counterstained lightly with hematoxylin.
Statistical analyses
Values presented are the means ± s.d. The significant differences in the ABR were determined using Student's paired t-test.
Results
Reconstitution by donor cells in chimeric mice
Flow cytometric analyses were carried out to check chimerism using the spleen cells of SAMP1 mice which had been reconstituted with bone marrow cells of BALB/c mice (BALB/c → SAMP1). Although SAMP1 mice carry the H-2 k antigen on the lymphocytes, more than 95% of the spleen cells from (BALB/c → SAMP1) chimeric mice were of donor (BALB/c) origin (H-2 d ) ( Figure 1 ).
Preventive effect of BMT on age-related impairment of mitogen responses in SAMP1 mice
The spleen cells of (BALB/c → SAMP1) chimeric mice (5 months old, 3 months after BMT) showed significantly higher responses to Con A and PHA than those of untreated SAMP1 mice of the same age ( Figure 2) ; the chimeric mice showed similar responses to young (2 months old) SAMP1 mice.
Preventive effect of BMT on age-related impairment of MLR in SAMP1 mice
In addition to the mitogen responses, MLR assays were performed to evaluate the functions of the newly developed T lymphocytes of (BALB/c → SAMP1) chimeric mice ( Figure 3) .
The response to the spleen cells of the third party (C57BL/6, H-2 b ) mice was significantly higher than those to autologous, BALB/c (H-2 d ), or SAMP1 (H-2 k ) mice in (BALB/c → SAMP1) chimeric mice. On the other hand, there was no significant difference between the responses to autologous SAMP1, C57BL/6, and BALB/c mice in SAMP1 mice at 5 months old. Values are shown as mean ± s.e. *P Ͻ 0.0001 between groups of (BALB/c → SAMP1) chimeric mice and SAMP1 of 5 months old in Con A response using Student's t-test. **P = 0.0018 between groups of (BALB/c → SAMP1) chimeric mice and SAMP1 of 5 months old in PHA response using Student's t-test. There is no significant difference in the ConA or PHA responses between groups of (BALB/c → SAMP1) chimeric mice and SAMP1 of 2 months old.
Preventive effect of BMT on age-related hearing loss in SAMP1 mice
Young (2 months old, 33.5 dBpeSPL) and old (5 months old, 51.6 dBpeSPL) SAMP1 mice showed significantly different thresholds, while similar mean thresholds were obtained in 2-and 5-month-old BALB/c mice (18.0 and 22.2 dBpeSPL, respectively), as shown in Table 1 . In contrast, the threshold (33.0 dBpeSPL) in (BALB/c → SAMP1) chimeric mice was significantly lower than that (51.6 dBpeSPL) in SAMP1 mice of the same age, and similar to the threshold (33.5 dBpeSPL) in young SAMP1 mice. a P Ͻ 0.001 compared with group C or E using Student's t-test. There is no significant difference between the thresholds of groups A and B or between groups C and E.
Bone Marrow Transplantation
Prevention of apoptosis in the spiral ganglion cells by BMT in SAMP1 mice
Although histopathological analyses were carried out to examine the missing or degenerated cells in the spiral ganglion, no difference was observed among young (2 months old) and old (5 months old) SAMP1 mice, BALB/c mice (5 months old), and (BALB/c → SAMP1) chimeric mice (5 months old, 3 months after BMT) (data not shown). As a next step, apoptotic cells were therefore examined using the TUNEL method. 18 Two to five spiral ganglion cells in three out of five animals in the group of old SAMP1 mice exhibited TUNEL positivity in the spiral ganglion cells in the middle to basal turn of the cochlea (Figure 4) . However, no TUNEL-positive cells were observed in the groups of (BALB/c → SAMP1) chimeric mice (5 months old, 3 months after BMT) mice or young SAMP1 and BALB/c mice (data not shown). 
Discussion
In the present study, we first confirmed using flow cytometric analyses that the immune system in (BALB/c → SAMP1) chimeric mice is reconstituted by donor (BALB/c) mice cells (Figure 1 ). We next confirmed that the age-related impairment of T cell functions in the mitogen responses ( Figure 2 ) and MLR ( Figure 3 ) is corrected after BMT. Third, we demonstrated that the agerelated auditory dysfunction is also ameliorated after BMT (Figure 4) . Fourth, we demonstrated that the apoptosis of the spiral ganglion cells (neurons) can be prevented in (BALB/c → SAMP1) chimeric mice ( Figure 5) .
Histopathologically, the spiral ganglion cells showed no remarkable change despite the development of hearing loss in old SAMP1 mice (5 months old) in the present study. This discrepancy may be due to the earlier development of the hearing dysfunction than the histopathological changes in the cochlea of SAMP1 mice. Saitoh et al 5 have demonstrated in a cochlear morphological study that the hearing impairment derives from the spiral ganglion degeneration; although SAMP1 mice showed progressive age-related hearing loss after 2 months of age, the significant degeneration of spiral ganglion cells was observed after 12 to 14 months of age in these mice.
In the present study, we have found TUNEL-positive cells in the spiral ganglion cells. Usami et al 18 also reported that four of six SAMP1 mice (10 months old) showed apoptotic change in various cells of the cochlea, while young SAMP1 (4-6 weeks old) mice did not. This seems to be due to the fact that SAMP1 mice show age-related hearing loss progressively, but slowly.
In the present study, we have succeeded in preventing both accelerated immunological dysfunctions and the development of hearing impairment in SAMP1 mice. These findings suggest that some types of accelerated presbycusis result not from defects in the cochlea, but from defects in the hematopoietic stem cells (HSCs), which differentiate into immunocompetent cells. Therefore, it is likely that allogeneic BMT, which replaces abnormal HSCs with normal HSCs and normalizes the immune function, has a preventive effect on presbycusis. Recently, Bunting et al 19 have demonstrated that retrovirus-mediated Janus kinase 3 (JAK3) gene transfer to bone marrow cells restores immune functions in a mouse model of severe combined immunodeficiency (SCID) caused by defects in JAK3-dependent cytokine signal pathways. SAMP1 mice have been reported to have some gene abnormalities which reduce the host immunity. 4, 7 Therefore, gene therapy using autologous HSCs may also have a therapeutic effect on both immunological dysfunctions and hearing impairment.
The relationship between immune dysfunction and hearing loss is still unclear. It has been shown that SAMP1 mice reveal an early increase of autoantibodies due to agerelated loss of immune regulation by T cells or due to the 'obtrusive' function of highly sensitized T cells in the aged. 4 We have previously shown that autoimmune mechanisms participate in the development of the sensori-neural hearing loss in MRL/lpr mice. 12, 13 We have also demonstrated that T cells in the systemic circulation infiltrate the inner ear and proliferate locally as a consequence of the immune response. 20 On the other hand, it has been shown that macrophages support the regeneration of the central and peripheral nervous system; 21, 22 the cells secrete interleukin-1 (IL-1) 23 and mediate the release of nerve growth factor (NGF) in a variety of tissues, including Schwann cells. NGF leads to increased neural survival and regeneration [26] [27] [28] and is involved in age-related neurodegenerative diseases, such as Alzheimer's disease. 27, 29 Komeda et al 30 have indicated that the blockage of IL-1 activity in the inner ear induces spiral ganglion degeneration. Subramanian et al 31 have recently demonstrated that activated T cells enter the central nervous system and modulate the development and function of bone marrowBone Marrow Transplantation derived macrophages as antigen-presenting cells in the T cell and/or BM cell transfer system. Therefore, it is conceivable that normal T cells of donor origin, when immune functions are normalized after BMT, improve neurogeneration in the inner ear, resulting in the prevention of accelerated degeneration of the spiral ganglion in SAMP1 mice. Further studies for relationship between T cell functions and degeneration may give additional information for the treatment for age-related diseases.
